Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
20.64
+0.16 (0.78%)
Nov 21, 2024, 4:00 PM EST

Chugai Pharmaceutical Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
982,743974,4931,039,247802,836633,314588,896
Upgrade
Other Revenue
159,607136,874220,699196,923153,63297,288
Upgrade
Revenue
1,142,3501,111,3671,259,946999,759786,946686,184
Upgrade
Revenue Growth (YoY)
-10.48%-11.79%26.02%27.04%14.68%18.35%
Upgrade
Cost of Revenue
337,168413,306476,251338,147273,465266,071
Upgrade
Gross Profit
805,182698,061783,695661,612513,481420,113
Upgrade
Selling, General & Admin
108,439112,580100,760102,41694,401101,574
Upgrade
Research & Development
171,068174,868149,626137,299117,850107,942
Upgrade
Other Operating Expenses
-14,503-28,561----
Upgrade
Operating Expenses
265,004258,887250,386239,715212,251209,516
Upgrade
Operating Income
540,178439,174533,309421,897301,230210,597
Upgrade
Interest Expense
-8-27-61-48-62-125
Upgrade
Interest & Investment Income
-4,67452--545
Upgrade
Other Non Operating Income (Expenses)
47--2,134-2,464-2,980-3,124
Upgrade
EBT Excluding Unusual Items
540,217443,821531,166419,385298,188207,893
Upgrade
Pretax Income
540,217443,821531,166419,385298,188207,893
Upgrade
Income Tax Expense
153,253118,349156,737116,39083,45550,333
Upgrade
Earnings From Continuing Operations
386,964325,472374,429302,995214,733157,560
Upgrade
Net Income
386,964325,472374,429302,995214,733157,560
Upgrade
Net Income to Common
386,964325,472374,429302,995214,733157,560
Upgrade
Net Income Growth
14.91%-13.08%23.58%41.10%36.29%70.36%
Upgrade
Shares Outstanding (Basic)
1,6451,6451,6451,6441,6431,642
Upgrade
Shares Outstanding (Diluted)
1,6461,6451,6451,6451,6451,645
Upgrade
Shares Change (YoY)
0.01%0.01%0.01%0.01%0.03%0.05%
Upgrade
EPS (Basic)
235.18197.83227.64184.29130.6695.95
Upgrade
EPS (Diluted)
235.15197.80227.57184.17130.5395.81
Upgrade
EPS Growth
14.90%-13.08%23.57%41.09%36.24%70.28%
Upgrade
Free Cash Flow
351,009337,977181,487213,657147,995153,632
Upgrade
Free Cash Flow Per Share
213.30205.39110.30129.8689.9693.42
Upgrade
Dividend Per Share
81.00080.00078.00076.00055.00032.000
Upgrade
Dividend Growth
102.50%2.56%2.63%38.18%71.88%11.63%
Upgrade
Gross Margin
70.48%62.81%62.20%66.18%65.25%61.22%
Upgrade
Operating Margin
47.29%39.52%42.33%42.20%38.28%30.69%
Upgrade
Profit Margin
33.87%29.29%29.72%30.31%27.29%22.96%
Upgrade
Free Cash Flow Margin
30.73%30.41%14.40%21.37%18.81%22.39%
Upgrade
EBITDA
567,090470,914564,743452,765331,606236,998
Upgrade
EBITDA Margin
49.64%42.37%44.82%45.29%42.14%34.54%
Upgrade
D&A For EBITDA
26,91231,74031,43430,86830,37626,401
Upgrade
EBIT
540,178439,174533,309421,897301,230210,597
Upgrade
EBIT Margin
47.29%39.52%42.33%42.20%38.28%30.69%
Upgrade
Effective Tax Rate
28.37%26.67%29.51%27.75%27.99%24.21%
Upgrade
Revenue as Reported
1,142,350-----
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.